1. Home
  2. KLTO vs CNFR Comparison

KLTO vs CNFR Comparison

Compare KLTO & CNFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KLTO
  • CNFR
  • Stock Information
  • Founded
  • KLTO 2019
  • CNFR 2009
  • Country
  • KLTO United States
  • CNFR United States
  • Employees
  • KLTO N/A
  • CNFR N/A
  • Industry
  • KLTO
  • CNFR Property-Casualty Insurers
  • Sector
  • KLTO
  • CNFR Finance
  • Exchange
  • KLTO NYSE
  • CNFR Nasdaq
  • Market Cap
  • KLTO 7.1M
  • CNFR 7.9M
  • IPO Year
  • KLTO N/A
  • CNFR 2015
  • Fundamental
  • Price
  • KLTO $0.21
  • CNFR $0.76
  • Analyst Decision
  • KLTO
  • CNFR
  • Analyst Count
  • KLTO 0
  • CNFR 0
  • Target Price
  • KLTO N/A
  • CNFR N/A
  • AVG Volume (30 Days)
  • KLTO 35.4M
  • CNFR 11.1K
  • Earning Date
  • KLTO 05-15-2025
  • CNFR 05-14-2025
  • Dividend Yield
  • KLTO N/A
  • CNFR N/A
  • EPS Growth
  • KLTO N/A
  • CNFR N/A
  • EPS
  • KLTO N/A
  • CNFR 1.96
  • Revenue
  • KLTO N/A
  • CNFR $64,021,000.00
  • Revenue This Year
  • KLTO N/A
  • CNFR $25.91
  • Revenue Next Year
  • KLTO N/A
  • CNFR N/A
  • P/E Ratio
  • KLTO N/A
  • CNFR $0.38
  • Revenue Growth
  • KLTO N/A
  • CNFR N/A
  • 52 Week Low
  • KLTO $0.11
  • CNFR $0.42
  • 52 Week High
  • KLTO $0.99
  • CNFR $1.91
  • Technical
  • Relative Strength Index (RSI)
  • KLTO N/A
  • CNFR 47.88
  • Support Level
  • KLTO N/A
  • CNFR $0.75
  • Resistance Level
  • KLTO N/A
  • CNFR $0.85
  • Average True Range (ATR)
  • KLTO 0.00
  • CNFR 0.03
  • MACD
  • KLTO 0.00
  • CNFR -0.01
  • Stochastic Oscillator
  • KLTO 0.00
  • CNFR 18.85

About KLTO KLOTHO NEUROSCIENCES INC

Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.

About CNFR Conifer Holdings Inc.

Conifer Holdings Inc is an insurance holding company. The company markets and services the product offerings of the company through specialty personal insurance business lines. The company offers insurance products in Texas, Illinois, and Indiana for homeowners lines and Nevada and Michigan for other lines. The revenues of the company are derived from premiums earned from insurance operations.

Share on Social Networks: